Clinical Trial Update: ROSE for Improved Molecular Marker Testing Via EBUS [NA]

View source ↗

Summary

A Johns Hopkins clinical trial is evaluating ROSE-enabled molecular marker testing via EBUS for non-small cell lung cancer and is currently enrolling by invitat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Johns Hopkins University | Conditions: Non-small Cell Lung Cancer (NSCLC) | NA | Status: ENROLLING_BY_INVITATION